ClinicalTrials.Veeva

Menu

Neuromuscular Block and Anesthetic Depth Monitoring

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Cholecystectomy, Laparoscopic

Treatments

Drug: Rocuronium (DB group)
Drug: Rocuronium (MB group)

Study type

Interventional

Funder types

Other

Identifiers

NCT02575443
ADMS NMD depth

Details and patient eligibility

About

The purpose of this study is to evaluated whether the depth of neuromuscular block may affect the unicon value of anesthetic depth monitoring system (ADMS).

Enrollment

60 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gall bladder disease
  • American Society of Anesthesiologist physical status 1 or 2

Exclusion criteria

  • Pregnancy
  • Body mass index < 16
  • Body mass index >30
  • Neuromuscular disease
  • Previous intraabdominal surgery

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Moderate block (MB) group
Experimental group
Treatment:
Drug: Rocuronium (MB group)
Deep block (DB) group
Experimental group
Treatment:
Drug: Rocuronium (DB group)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems